Literature DB >> 35653286

The National Partnership to Improve Dementia Care and Hospital Readmission Among Skilled Nursing Facility Residents.

Sijiu Wang1, Helena Temkin-Greener2, Yeates Conwell3, Shubing Cai2.   

Abstract

The National Partnership to Improve Dementia Care in Nursing Homes (i.e., the National Partnership) was launched in March 2012. Using national Medicare, Minimum Data Set, and Nursing Home Compare data in CY 2010-2014, we examined changes in hospital readmissions for older post-acute skilled nursing facility (SNF) residents with Alzheimer's disease or related dementias (ADRD) following the National Partnership. Using residents without ADRD as reference group to control for concurrent policy and SNF quality changes, we estimated linear probability models to examine the relationship between readmissions and the National Partnership for residents with ADRD, and also stratified the analysis by quality of SNFs. We found a decreasing trend in hospital readmissions over time. The risk of readmissions in residents with ADRD decreased additional 0.3 percentage-points (p < .01) after the launch of the National Partnership. This relationship varied across SNFs with different quality, as it was stronger in high-quality compared to low-quality SNFs.

Entities:  

Keywords:  antipsychotics; dementia; hospital readmission; nursing homes; the national partnership to improve dementia care in nursing homes

Mesh:

Year:  2022        PMID: 35653286      PMCID: PMC9482945          DOI: 10.1177/07334648221102402

Source DB:  PubMed          Journal:  J Appl Gerontol        ISSN: 0733-4648


  22 in total

1.  Potentially avoidable hospitalizations of nursing home residents: frequency, causes, and costs: [see editorial comments by Drs. Jean F. Wyman and William R. Hazzard, pp 760-761].

Authors:  Joseph G Ouslander; Gerri Lamb; Mary Perloe; JoVonn H Givens; Linda Kluge; Tracy Rutland; Adam Atherly; Debra Saliba
Journal:  J Am Geriatr Soc       Date:  2010-04       Impact factor: 5.562

2.  Policy to Reduce Antipsychotic Use and Hospitalization of Nursing Home Residents With Dementia.

Authors:  Sijiu Wang; Helena Temkin-Greener; Yeates Conwell; Shubing Cai
Journal:  J Am Med Dir Assoc       Date:  2020-06-09       Impact factor: 4.669

3.  Antipsychotic therapy and short-term serious events in older adults with dementia.

Authors:  Paula A Rochon; Sharon-Lise Normand; Tara Gomes; Sudeep S Gill; Geoffrey M Anderson; Magda Melo; Kathy Sykora; Lorraine Lipscombe; Chaim M Bell; Jerry H Gurwitz
Journal:  Arch Intern Med       Date:  2008-05-26

4.  Reducing Excessive Use of Antipsychotic Agents in Nursing Homes.

Authors:  Jerry H Gurwitz; Alice Bonner; Donald M Berwick
Journal:  JAMA       Date:  2017-07-11       Impact factor: 56.272

5.  Nonpharmacologic management of behavioral symptoms in dementia.

Authors:  Laura N Gitlin; Helen C Kales; Constantine G Lyketsos
Journal:  JAMA       Date:  2012-11-21       Impact factor: 56.272

6.  Low-Quality Nursing Homes Were More Likely Than Other Nursing Homes To Be Bought Or Sold By Chains In 1993-2010.

Authors:  David C Grabowski; Richard A Hirth; Orna Intrator; Yue Li; John Richardson; David G Stevenson; Qing Zheng; Jane Banaszak-Holl
Journal:  Health Aff (Millwood)       Date:  2016-05-01       Impact factor: 6.301

7.  Dangerous wandering: elopements of older adults with dementia from long-term care facilities.

Authors:  Myra A Aud
Journal:  Am J Alzheimers Dis Other Demen       Date:  2004 Nov-Dec       Impact factor: 2.035

8.  The Minimum Data Set 3.0 Cognitive Function Scale.

Authors:  Kali S Thomas; David Dosa; Andrea Wysocki; Vincent Mor
Journal:  Med Care       Date:  2017-09       Impact factor: 2.983

9.  Antipsychotic drug use among elderly nursing home residents in the United States.

Authors:  Pravin Kamble; Hua Chen; Jeff Sherer; Rajender R Aparasu
Journal:  Am J Geriatr Pharmacother       Date:  2008-10

Review 10.  Management of the behavioral and psychological symptoms of dementia.

Authors:  Elizabeth C Hersch; Sharon Falzgraf
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.